COVID-19 is an emerging, rapidly evolving situation.
COVID-19 public health info from US CDC | COVID-19 research info from the US NIH | COVID-19 resources for global health researchers
International Tobacco and Health Research and Capacity Building Program Review
After 10 years of investing in tobacco cessation projects, Fogarty conducted a review of its International Tobacco and Health Research and Capacity Building Program. The report, guided by the Fogarty Framework for Program Assessment, analyzes program implementation, and identifies near-term and long-term outputs, outcomes and impacts.
Established in 2002, Fogarty's Tobacco Program solicits collaborative research and capacity building projects that address the burden of tobacco use in low-and middle-income countries (LMICs) by:
- Pursuing observational, intervention and policy research of LMIC relevance
- Building capacity in epidemiological, biological and behavioral research, prevention, treatment, communications, implementation, health services and policy research
Through the Tobacco Program, Fogarty and its partnering Institutions - the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and Office of Behavioral and Social Sciences Research (OBSSR) at NIH - have sought to increase collaborations between investigators in the U.S. and other high-income countries, and researchers, institutions and scientists in LMICs.
The report describes the results of the Tobacco Program review. After a brief background and description of review methodology, review findings and recommendations are then detailed. Appendices include a full list of awards and additional documents to support the analyses presented. Conducted through Fogarty's Center for Global Health Studies (CGHS), in partnership with OBSSR, NCI and NIDA, the report is part of a larger tobacco-related initiative.
To view Adobe PDF files, download current, free accessible plug-ins from the Adobe's website.
Updated November 25, 2013